Fianlimab (REGN3767) is a monoclonal antibody targeting LAG-3 (Lymphocyte Activation Gene 3) in humans, exhibiting antitumor activity. It can be used to study melanoma.
Purity:
99.04%
CAS Number:
[2126132-98-5]
Target:
LAG-3
* VAT and and shipping costs not included. Errors and price changes excepted